NET CONNECT Update from ESMO 2019
NET CONNECT has summarised highlights of the recent ESMO 2019 meeting for you
Neuroendocrine Tumour Update by Dr. Angela Lamarca, The Christie NHS Foundation Trust / University of Manchester, UK
Hello on behalf of CORONARY CONNECT my name is Jan Přeček. I'm a cardiologist from the University Hospital Olomouc in the Czech Republic.
I'd like to talk about safety of low levels of LDL cholesterol (LDL-C).
LDL-C as a Risk Factor
Elevated LDL-C is a clearly established major risk factor for the development of atherosclerotic cardiovascular disease.
Risk reduction of atherosclerotic cardiovascular disease is proportional to the absolute and relative LDL-C reduction achieved.
In other words, there seems to be no LDL-C threshold, below which no further atherosclerotic cardiovascular disease prevention can be achieved.
Please respond on a scale of 1 to 5 (5=strongly agree).